BlackRock, Inc. - 31 Dec 2025 SCHEDULE 13G/A Report for Taysha Gene Therapies Inc Common Stock (TSHA)

Filing Manager
BlackRock, Inc.
Reporting Manager
BlackRock, Inc.
Security
Taysha Gene Therapies Inc Common Stock
Symbol
TSHA
Shares outstanding
274,650,631 shares
Disclosed Ownership
17,852,291 shares
Ownership
6.5%
Form type
SCHEDULE 13G/A
Filing time
21 Jan 2026, 12:30:35 UTC
Date of event
31 Dec 2025
Previous filing
16 Jul 2025
SEC
View on sec.gov

Quoteable Key Fact

"BlackRock, Inc. disclosed 6.5% ownership in Taysha Gene Therapies Inc Common Stock (TSHA) on 31 Dec 2025."

Quick Takeaways

  • BlackRock, Inc. filed SCHEDULE 13G/A for Taysha Gene Therapies Inc Common Stock (TSHA).
  • Disclosed ownership: 6.5%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 16 Jul 2025.
  • Current filing was accepted on 21 Jan 2026, 12:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BlackRock, Inc. 6.5% 17,852,291 17,558,530 0 Spencer Fleming Managing Director